| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |